57 related articles for article (PubMed ID: 12439335)
1. Synergistic and antagonistic combinations of drugs in human prostate cancer cell lines in vitro.
Budman DR; Calabro A; Kreis W
Anticancer Drugs; 2002 Nov; 13(10):1011-6. PubMed ID: 12439335
[TBL] [Abstract][Full Text] [Related]
2. Melding a New 3-Dimensional Agarose Colony Assay with the E(max) Model to Determine the Effects of Drug Combinations on Cancer Cells.
Kajiwara Y; Panchabhai S; Liu DD; Kong M; Lee JJ; Levin VA
Technol Cancer Res Treat; 2009 Apr; 8(2):163-76. PubMed ID: 19334798
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Interaction of CPP2 Coupled with Thiazole Derivates Combined with Clotrimazole and Antineoplastic Drugs in Prostate and Colon Cancer Cell Lines.
Duarte D; Vale N
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769414
[TBL] [Abstract][Full Text] [Related]
4. Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment.
Rushworth LK; Hewit K; Munnings-Tomes S; Somani S; James D; Shanks E; Dufès C; Straube A; Patel R; Leung HY
Br J Cancer; 2020 Feb; 122(4):517-527. PubMed ID: 31844184
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells.
Wang X; Xuetao X; Wu M; Wu P; Sheng Z; Liu W; Ma YY; Zhao DG; Zhang K; Li D; Zheng X; Goodin S
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):542-553. PubMed ID: 34986722
[TBL] [Abstract][Full Text] [Related]
6. SNSynergy: Similarity network-based machine learning framework for synergy prediction towards new cell lines and new anticancer drug combinations.
Huangfu X; Zhang C; Li H; Li S; Li Y
Comput Biol Chem; 2024 Jun; 110():108054. PubMed ID: 38522389
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Cytotoxic Effect from Combination of Wedelolactone and Cisplatin in HeLa Cell Line: A Novel Finding.
Sarwar S; Yu JQ; Nadeem H; Huq F
Drug Des Devel Ther; 2020; 14():3841-3852. PubMed ID: 33061291
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic Action of Palladium-Based Compound on Prostate Stem Cells, Primary Prostate Epithelial Cells, Prostate Epithelial Cells, and Prostate Cell Lines.
Cheng L; Wang Y; Wang J; Qin H; Zhu G; Tao L
J Healthc Eng; 2022; 2022():4993405. PubMed ID: 35345664
[TBL] [Abstract][Full Text] [Related]
9. 2,4-dinitrophenol enhances cisplatin and etoposide cytotoxic activity on prostate cancer cell line.
Adamczuk G; Humeniuk E; Adamczuk K; Grabarska A; Madej-Czerwonka B; Michalczuk M; Korga-Plewko A; Dudka J
Ann Agric Environ Med; 2024 Mar; 31(1):37-46. PubMed ID: 38549475
[TBL] [Abstract][Full Text] [Related]
10. Prazosin but Not Tamsulosin Sensitises PC-3 and LNCaP Prostate Cancer Cells to Docetaxel.
Spencer BH; McDermott CM; Chess-Williams R; Christie D; Anoopkumar-Dukie S
Pharmacology; 2018 Apr; 102(1-2):10-18. PubMed ID: 29669348
[TBL] [Abstract][Full Text] [Related]
11. Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs.
Abd El-Hafeez T; Shams MY; Elshaier YAMM; Farghaly HM; Hassanien AE
Sci Rep; 2024 Jan; 14(1):2428. PubMed ID: 38287066
[TBL] [Abstract][Full Text] [Related]
12. Drug antagonism and single-agent dominance result from differences in death kinetics.
Richards R; Schwartz HR; Honeywell ME; Stewart MS; Cruz-Gordillo P; Joyce AJ; Landry BD; Lee MJ
Nat Chem Biol; 2020 Jul; 16(7):791-800. PubMed ID: 32251407
[TBL] [Abstract][Full Text] [Related]
13. How valid are claims for synergy in published clinical studies?
Ocana A; Amir E; Yeung C; Seruga B; Tannock IF
Ann Oncol; 2012 Aug; 23(8):2161-2166. PubMed ID: 22314859
[TBL] [Abstract][Full Text] [Related]
14. Preparation, Optimization, and In-Vitro Evaluation of Brusatol- and Docetaxel-Loaded Nanoparticles for the Treatment of Prostate Cancer.
Adekiya TA; Moore M; Thomas M; Lake G; Hudson T; Adesina SK
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258124
[TBL] [Abstract][Full Text] [Related]
15. Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.
Bashi AC; Coker EA; Bulusu KC; Jaaks P; Crafter C; Lightfoot H; Milo M; McCarten K; Jenkins DF; van der Meer D; Lynch JT; Barthorpe S; Andersen CL; Barry ST; Beck A; Cidado J; Gordon JA; Hall C; Hall J; Mali I; Mironenko T; Mongeon K; Morris J; Richardson L; Smith PD; Tavana O; Tolley C; Thomas F; Willis BS; Yang W; O'Connor MJ; McDermott U; Critchlow SE; Drew L; Fawell SE; Mettetal JT; Garnett MJ
Cancer Discov; 2024 May; 14(5):846-865. PubMed ID: 38456804
[TBL] [Abstract][Full Text] [Related]
16. Evaluations of Anticancer Effects of Combinations of Cisplatin and Tirucallane-Type Triterpenes Isolated from Amphipterygium adstringens (Schltdl).
Díaz-Sánchez L; Zentella-Dehesa A; Castro-Torres VA; Silva-Jiménez N; Jacobo-Herrera NJ; Martínez-Vázquez M
Chem Biodivers; 2023 Oct; 20(10):e202300893. PubMed ID: 37695827
[TBL] [Abstract][Full Text] [Related]
17. A granularity-level information fusion strategy on hypergraph transformer for predicting synergistic effects of anticancer drugs.
Wang W; Yuan G; Wan S; Zheng Z; Liu D; Zhang H; Li J; Zhou Y; Wang X
Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38243692
[TBL] [Abstract][Full Text] [Related]
18.
Ganot N; Tshuva EY
RSC Adv; 2018 Feb; 8(11):5822-5827. PubMed ID: 30009018
[TBL] [Abstract][Full Text] [Related]
19. Extraction, phytochemical characterization and anti-cancer mechanism of Haritaki churna: An ayurvedic formulation.
Khan MRUZ; Yanase E; Trivedi V
PLoS One; 2023; 18(5):e0286274. PubMed ID: 37256897
[TBL] [Abstract][Full Text] [Related]
20. Nanotherapeutic Approach to Delivery of Chemo- and Gene Therapy for Organ-Confined and Advanced Castration-Resistant Prostate Cancer.
Sharma S; Mahajan SD; Chevli K; Schwartz SA; Aalinkeel R
Crit Rev Ther Drug Carrier Syst; 2023; 40(4):69-100. PubMed ID: 37075068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
